ArticleCancers2024

Multidrug-Resistant Profiles in Non-Small Cell Lung Carcinoma Patient-Derived Cells: Implications for Personalized Approaches with Tyrosine Kinase Inhibitors.

Jelena Dinić et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.